|
Market Analysis Reports of Glucocorticoid receptor agonist
|
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H2 2018 Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H2 2018 SUMMARY ...
Tumor Necrosis Factor Receptor Superfamily Member 18 - Pipeline Review, H2 2019 Tumor Necrosis Factor Receptor Superfamily Member 18 - Pipeline Review, H2 2019 SUMMARY Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or ...
Zalicus Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... the anti-inflammatory benefits of glucocorticoids, without associated dose-dependent ... containing low doses of the glucocorticoid prednisolone acetate and the ... discovered that adenosine A2A receptor agonists (A2A) agonists synergize with existing and ...
Asthma Treatment Drugs Market Research (China) China's demand for Asthma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive ...
2020 Post-Traumatic Stress Disorder (PTSD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... ) inhibitor; GABA A receptor agonists; GABA aminotransferase inhibitor; Glucocorticoid receptor antagonist; glucocorticoid receptor II antagonists; glutamate receptor inhibitor; HDAC3 ...
2020 Alcohol Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... receptor agonist; Dopamine uptake inhibitors; GABA A receptor antagonist; GABA B receptor agonists; Ghrelin receptor inverse agonist; Glucocorticoid receptor II (GR) antagonists; Histamine H1 receptor ...
Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) - By ALD Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By NAFLD Stages (Steatosis, NASH) ... Drug (Opiod Antagonist, Glucocorticoid, Pentoxifyline, Antioxidants, Granulocyte ... -2022): (Opioid Antagonist ,Glucocorticoid, Pentoxifyline, Antioxidants, Granulocyte ... , Hypolipidemic Agents, FXR receptor agonist, Elafibranoer) Regional Markets – ...
Asthma Treatment Drugs Industry Forecasts - China Focus This study focuses on China’s Asthma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have ...
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology This product consists of four reports in pdf format describing the competitive field of new molecular entities directed against inibitory as well stimulatory immune ...
2020 Drug Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... Amide Hydrolase) inhibitor; GABA A receptor agonists; Glucocorticoid receptor antagonists; GABA B receptor modulators; gamma opioid antagonist ...
Competitor Analysis: Targeted Therapy of Diabetes ... -1B (PTP-1B) Inhibitors Glucagon Receptor (GCGR) Antagonists Glucocorticoid Receptor (GCGR) Antagonists Novel Insulin ... Sensitizers G-Protein Coupled Receptor 119 (GPR119) Agonists ...
Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators This product consists of four reports in pdf format describing the competitive field of new molecular entities directed against inibitory as well stimulatory immune checkpoints on ...
2020 Nicotine Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... antagonist; Cannabinoid receptor antagonist; Cannabinoid receptor modulators; glucocorticoid receptor antagonist; metabotropic glutamate receptor 2 (mGlu2) agonist; Nicotinic antagonists ...
Asthma Treatment Drugs Companies in China This study focuses on China’s Asthma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer ...
Antipsychotic Drugs: Technologies and Global Markets ... D2 antagonists, D2/5HT2A antagonists and D2 partial agonists. The market size includes both ... An understanding on receptor target of antipsychotic drugs, including dopamine, serotonin, glutamate, tachykinin and glucocorticoid ...
Global Prednisolone Sodium Phosphate API Market Growth 2024-2030 ... immunomodulating properties. As a glucocorticoid receptor agonist, prednisolone sodium phosphate binds to specific intracellular glucocorticoid receptors, and causes ...
Global Prednisolone Sodium Phosphate API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 ... immunomodulating properties. As a glucocorticoid receptor agonist, prednisolone sodium phosphate binds to specific intracellular glucocorticoid receptors, and causes ...
2020 Neuromyelitis Optica (Devic's Syndrome) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... ; Cytotoxic T lymphocyte stimulants; Estrogen receptor agonists; Interleukin 6 receptor antagonists; Monoacylglycerol lipase inhibitors ... Serum-glucocorticoid regulated kinase stimulants; STAT3 transcription factor inhibitors; Steroid receptor agonists; T ...
Global Butenafine Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 ... a CAGR of % during review period. It is a glucocorticoid receptor agonist and synthetic glucocorticoids. Our consistent efforts and ...
Global Butenafine Hydrochloride Market Growth 2024-2030 ... by the Butenafine Hydrochloride market. It is a glucocorticoid receptor agonist and synthetic glucocorticoids. Our consistent efforts and ...
|
|
|